LabCorp Pays $106.7 Million for Monogram Biosciences in Personalized Medicine Play

Acquisition adds more companion diagnostics to LabCorp’s molecular test menu Here’s another validation of the prediction that companion diagnostics will be a cornerstone of personalized medicine. Laboratory Corporation of America Holdings (NYSE: LH) of Burlington, North Carolina, said Tuesday (June 23) it would acquire Monogram Biosciences, Inc. (NASDAQ: MGRM) of South San Francisco, California. In an all cash deal totaling $106.7 million, LabCorp will pay $4.55 per share. “Monogram...
;